腋窝淋巴结清扫术中预防性淋巴静脉旁路术的国家趋势与安全性:基于NSQIP数据库61,819例患者的十年分析
该回顾性队列研究利用美国外科医师学会NSQIP数据库2013-2022年61,819例腋窝淋巴结清扫(ALND)病例,其中572例(0.93%)同期行预防性淋巴静脉旁路术(LVB)。结果显示LVB使用率呈显著线性增长(每年0.24%;R²=0.88;p<0.001),十年间增长14.6倍;LVB患者总体并发症(9.3% vs. 7.0%;p=0.040)、深静脉血栓(DVT)(0.7% vs. 0.2%;p=0.032)和表浅手术部位感染(SSI)(4.5% vs. 2.7%;p=0.014)发生率较高,但再手术率相当。
要点
- 预防性LVB在ALND中的使用率十年间增长14.6倍,呈显著线性增长。
- LVB与总体并发症、DVT和表浅SSI风险升高相关,但再手术率相当。
- 多因素分析显示LVB有降低再手术风险的趋势(OR 0.64;95%CI 0.40-1.01;p=0.056)。
核心结论
- 预防性LVB在ALND中的使用率十年间增长14.6倍,虽在部分亚组中并发症和DVT增加,但再手术率与单纯ALND相当,提示淋巴显微外科正逐步融入乳腺癌诊疗。
研究设计与样本
- 回顾性队列研究,利用美国外科医师学会NSQIP数据库2013-2022年数据,分析61,819例ALND病例,其中572例(0.93%)同期行LVB。
主要发现
- LVB使用率呈显著线性增长(每年0.24%;R²=0.88;p<0.001),COVID-19期间(2019-2021年)从1.54%升至2.10%。
- LVB患者总体并发症发生率9.3% vs. 7.0%(p=0.040),DVT发生率0.7% vs. 0.2%(p=0.032),表浅SSI发生率4.5% vs. 2.7%(p=0.014)。
- 再手术率、伤口裂开率和深部SSI发生率在两组间相当。
- 在未行乳房再造的乳房切除术患者中,LVB组DVT发生率升高(1.3% vs. 0.2%;p=0.042)。
- 多因素分析显示LVB与再手术风险降低有趋势性关联(OR 0.64;95%CI 0.40-1.01;p=0.056)。
临床怎么用
- 在ALND中考虑预防性LVB时,应权衡其可能的淋巴水肿预防获益与增加的总体并发症、DVT和表浅SSI风险。
- 对于未行乳房再造的乳房切除术患者,行LVB时需特别关注DVT风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-mastectomy lymphatic reconstruction is increasingly common, yet its frequency and outcomes remain underexplored. This study evaluates national trends and safety outcomes of prophylactic lymphovenous bypass (LVB) following axillary lymph node dissection (ALND) over a 10-year period, including the COVID-19 era. METHODS: A retrospective cohort study using the American College of Surgeons National Surgery Quality Improvement Program database from 2013-2022 analyzed 61,819 ALND cases, including 572 (0.93%) with concurrent LVB. LVB cases were identified via CPT codes (38999, 38308, 35206, 35236, 38305). Primary analysis evaluated temporal adoption trends. Secondary endpoints included 30-day postoperative complications [reoperation, deep vein thrombosis (DVT), wound dehiscence, surgical site infection (SSI), and sepsis]. RESULTS: LVB adoption increased steadily over the study period, demonstrating significant linear growth (0.24% annually; R²=0.88; p<0.001). Rates increased from 1.54 to 2.10% during the COVID-19 pandemic from 2019 to 2021. LVB patients had higher rates of any postoperative complication (9.3 vs. 7.0%; p=0.040), DVT (0.7 vs. 0.2%; p=0.032), and superficial SSI (4.5 vs. 2.7%; p=0.014). Rates of reoperation, wound dehiscence, and deep SSI were comparable. Among mastectomy patients without reconstruction, LVB patients had an increased rate of DVT (1.3 vs. 0.2%; p=0.042). Multivariate analysis trended toward decreased reoperation risk with LVB (OR 0.64; 95% CI 0.40-1.01; p=0.056). CONCLUSION: This decade-long analysis demonstrates a 14.6-fold rise in prophylactic LVB during ALND. Although LVB had increased complications and DVT in select subgroups, reoperation rates were comparable to ALND alone. The trend toward reduced reoperation risk and expanding national use indicates increasing integration of lymphatic microsurgery into breast cancer care.
引用
- Pham KT, Dagi AF, Ly CL, et al. National trends and safety of prophylactic lymphovenous bypass during axillary lymph node dissection: A decade-long analysis of 61,819 patients through the NSQIP database. J Plast Reconstr Aesthet Surg. 2026. PMID: 42161165. doi:10.1016/j.bjps.2026.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。